Book your Flu and/or Covid-19 vaccines now - use your online booking link in your text or email invitation.
Invitations are currently being sent out to our eligible patient groups. Use the online booking link in your text or email invite. Remember to use the dropdown menu to change the site and choose a date and time.

Get help from your GP by completing your health form

Key Information:

  • Why You Were Invited: You may have received an invitation for an RSV vaccine. This video explains why this new vaccine is essential for preventing serious illness in older adults and newborns.
  • What is RSV?: Respiratory Syncytial Virus (RSV) is a common winter virus. While it usually causes mild coughs and colds in healthy adults, it can cause severe lung infections like bronchiolitis and pneumonia in vulnerable groups.

Who Needs the Vaccine?

There are two distinct groups invited for this vaccine, but for two very different reasons:

  1. Adults Aged 75 to 79
    • The Goal: To protect you.
    • The Reason: As we get older, our immune system becomes less able to fight off viruses. This vaccine gives you direct protection and significantly reduces your risk of hospitalisation from severe lung infections.
  2. Pregnant People
    • The Goal: To protect your baby.
    • The Reason: By getting the vaccine during pregnancy, your body creates protective antibodies. These are passed to your baby, giving them crucial protection against RSV during their first few months of life when they are most vulnerable.

What Happens Next?

This is a safe and effective way to protect those most at risk. We strongly encourage you to take up this offer.

Please follow the instructions in the text message invitation you received to book your appointment. If you have missed your invite or have questions, please contact us.

Discuss the RSV Vaccine


Further Information

For more information on RSV and the RSV vaccination programme, please visit the NHS website.

Learn more about RSV

Learn more about the RSV vaccine


Last reviewed: 26 December 2025
Next review due: 26 December 2028